The U.S. Food and Drug Administration on Wednesday granted De Novo authorization for Johnson & Johnson’s OTTAVA Robotic Surgical System, marking the regulatory clearance of the world’s first table-integrated soft tissue robotic platform. The marketing clearance encompasses multiple general surgery...
Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
308last 24h
2124last 7d
377● bullish (7d)
185● bearish (7d)
204publishers
Benzinga19d agobullish
FDA Approves Johnson & Johnson Table-Integrated OTTAVA Robotic Surgery SystemMedTech Dive35d agobullish
J&J wins FDA approval for dual-energy ablation catheterJohnson & Johnson expects U.S. physicians to perform the first procedures with the device this summer as it starts a phased commercial rollout.